Preparation and Evaluation of Pioglitazone Tablet by Solid Dispersion Technique
Journal of Drug Discovery and Therapeutics · 2023
DOI: 10.32553/jddt.v11i3.468 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Drug Discovery and Therapeutics, 2023. Verfasst von Parag Sharma und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Pioglitazone is an oral hypoglycemic drug, used for the treatment of type 2 diabetes. The main objectives of this study were to improve aqueous solubility of Pioglitazone by preparing its solid dispersion by fusion method using various carriers that will improve its absorption and subsequent bioavailability. The prepared tablets (TF1-TF5) were evaluated for various parameters i.e.shape and size, weight variation, hardness, friability, disintegration time, drug content etc. The prepared tablet passed all the tests.Finally, it can be concluded that solid dispersion of Pioglitazone may be prepared to improve its solubility and dissolution. This will lead to better absorption and hence improved bioavailability of the drug (Pioglitazone).
Zitieren
APA
Sharma, P., Sharma, D. V., & Ravindra, D. N. (2023). Preparation and Evaluation of Pioglitazone Tablet by Solid Dispersion Technique. Journal of Drug Discovery and Therapeutics. https://doi.org/10.32553/jddt.v11i3.468
Vancouver
Sharma P, Sharma DV, Ravindra DN. Preparation and Evaluation of Pioglitazone Tablet by Solid Dispersion Technique. Journal of Drug Discovery and Therapeutics. 2023. doi:10.32553/jddt.v11i3.468
BibTeX
@article{Sharma2023,
author = {Sharma, Parag and Sharma, Dr. Vijay and Ravindra, Dr. N.},
title = {Preparation and Evaluation of Pioglitazone Tablet by Solid Dispersion Technique},
journal = {Journal of Drug Discovery and Therapeutics},
year = {2023},
doi = {10.32553/jddt.v11i3.468}
}
EUVIMED